Skip to main content
Premium Trial:

Request an Annual Quote

Scynexis Expands ACD Processing Tools Installation

NEW YORK, April 19 (GenomeWeb News) - Scynexis, a drug-discovery and -development company, has expanded its installation of Advanced Chemistry Development's ACD/1D NMR Processor, the companies said today.

 

The expanded nuclear magnetic resonance processing capabilities have been added to Scynexis' research facility in Research Triangle Park, NC, the companies said.

 

ACD claims that the tool eases the interpretation of NMR data through multiplet analysis, verification, and quantitation techniques, cutting NMR interpretation and dissemination times.

 

Financial details were not discussed.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.